Liposome Composition Comprising Sphingomonas Olei Culture Extract for Skin Delivery
Summary
USPTO published patent application US20260096958A1 by six inventors including Won Woo Choi and Byong Jun Choi for a liposome composition encapsulating Sphingomonas olei culture extract for enhanced skin regeneration and transdermal absorption. The application covers cosmetic compositions for topical skin delivery applications, classified under CPC codes A61K 8/14 and A61Q 19/00.
What changed
USPTO published patent application US20260096958A1 describing a liposome composition that encapsulates Sphingomonas olei culture extract to improve transdermal delivery and skin regeneration efficacy. The composition includes liposome carriers that protect and deliver the bacterial culture extract through the skin barrier.
Cosmetic and pharmaceutical companies developing topical skin care formulations should review this application to assess potential competitive implications or licensing opportunities. The patent covers methods for enhanced transdermal absorption using bacterial culture extracts in liposomal delivery systems.
What to do next
- Monitor patent prosecution status
- Review for freedom-to-operate if developing similar cosmetic formulations
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
LIPOSOME COMPOSITION COMPRISING CULTURE EXTRACT OF SPHINGOMONAS OLEI
Application US20260096958A1 Kind: A1 Apr 09, 2026
Inventors
Won Woo CHOI, Min Ji PARK, Byong Jun CHOI, Chi Hyun PARK, Jang Ho PARK, Yung Jae KIM
Abstract
The present disclosure relates to a liposome composition including a culture extract of Sphingomonas olei and a cosmetic composition including the same. The liposomal composition according to the present disclosure encapsulates an extract of Sphingomonas olei culture broth in liposome, thereby efficiently delivering the culture extract of Sphingomonas olei into the skin and thus exhibiting enhanced skin regeneration efficacy and improved transdermal absorption.
CPC Classifications
A61K 8/14 A61K 8/0245 A61K 8/345 A61K 8/37 A61K 8/4973 A61K 8/553 A61K 8/99 A61Q 19/00 A61K 2800/413
Filing Date
2025-12-02
Application No.
19405846
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.